Kaufman Richard E 4
4 · Intersect ENT, Inc. · Filed Jul 12, 2018
Insider Transaction Report
Form 4
Kaufman Richard E
See Remarks
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2018-07-10−7,000→ 35,000 totalExercise: $13.05Exp: 2027-01-17→ Common Stock (7,000 underlying) - Sale
Common Stock
2018-07-10$35.02/sh−7,000$245,126→ 87,512 total - Exercise/Conversion
Common Stock
2018-07-10$13.05/sh+7,000$91,350→ 94,512 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2018.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.90 to $35.50, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]The vesting commencement date of the option is January 1, 2017. 1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months.